[ Mirexus Biotechnologies raises $12M in Venture ]
Mirexus Biotechnologies has raised $12 million in Venture funding.
Founded in 2008, Mirexus Biotechnologies is a natural nanomaterials company that develops novel technology based on polysaccharide nanoparticles.
The new financing will be used to finance a factory to produce PhytoSpherix™, to boost business development, particularly in the Personal Care market, and increase R&D to develop new personal care, nutraceutical, and biomedical applications.
|Founder / CEO||Phil Whiting|
|Previous Investors||Asahi Kasei|